Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Comparison between dupilumab a...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore

Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore

Bibliographic Details
Main Authors: Yik Weng Yew, MBBS, MPH, PhD, Pei Ming Yeo, MBBS, MRCP
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:JAAD International
Subjects:
atopic dermatitis
baricitinib
clinical research
drug response
dupilumab
janus kinase inhibitors
Online Access:http://www.sciencedirect.com/science/article/pii/S2666328723000949
  • Holdings
  • Description
  • Similar Items
  • Staff View
Description
ISSN:2666-3287

Similar Items

  • Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based review
    by: Siddhartha Sood, HBSc, et al.
    Published: (2024-09-01)
  • Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect
    by: Leore Lavin, MSc, et al.
    Published: (2024-07-01)
  • Baricitinib for atopic dermatitis patients who responded inadequately to dupilumab treatment: First daily practice results
    by: Linde deWijs, et al.
    Published: (2022-12-01)
  • Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
    by: Huijuan Fang, et al.
    Published: (2024-06-01)
  • Immediate exacerbation of atopic dermatitis after switching from upadacitinib to dupilumab: A report of two cases
    by: Makoto Ito, et al.
    Published: (2023-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs